{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:57:31Z","timestamp":1790117851563,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.contraception.2008.06.012","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T20:37:12Z","timestamp":1218659832000},"page":"377-383","source":"Crossref","is-referenced-by-count":25,"title":["Risk of hyperkalemia in women taking ethinylestradiol\/drospirenone and other oral contraceptives"],"prefix":"10.1016","volume":"78","author":[{"given":"Jeanne","family":"Loughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Mona","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Foegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Robin","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cutone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.06.012_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the randomized aldactone evaluation study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2008.06.012_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjhyper.2004.12.003","article-title":"Effects of drospirenone\/17-b estradiol on blood pressure and potassium balance in hypertensive postmenopausal women","volume":"18","author":"Preston","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.contraception.2008.06.012_bib6","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMe030030","article-title":"Aldosterone blockade and heart failure","volume":"348","author":"Jessup","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.contraception.2008.06.012_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/oxfordjournals.aje.a010011","article-title":"Invited commentary: propensity scores","volume":"150","author":"Joffee","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2008.06.012_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2307\/2533160","article-title":"Matching using estimated propensity scores: relating theory to practice","volume":"52","author":"Rubin","year":"1996","journal-title":"Biometrics"},{"key":"10.1016\/j.contraception.2008.06.012_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/pds.1062","article-title":"An application of propensity score matching using claims data","volume":"14","author":"Seeger","year":"2005","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.contraception.2008.06.012_bib12","series-title":"Epidemiology. An introduction","author":"Rothman","year":"2002"},{"key":"10.1016\/j.contraception.2008.06.012_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0010-4825(92)90023-G","article-title":"Simple SAS macros for the calculation of exact binomial and Poisson confidence limits","volume":"22","author":"Daly","year":"1992","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib14","series-title":"SAS\/STAT, Version 8.2","year":"2001"},{"key":"10.1016\/j.contraception.2008.06.012_bib15","series-title":"Stata Statistical Software: Release 6","year":"1999"},{"key":"10.1016\/j.contraception.2008.06.012_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/pds.1554","article-title":"Supplemental data collection with case-cohort analysis to address confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores","volume":"17","author":"Eng","year":"2008","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.contraception.2008.06.012_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2005.06.010","article-title":"The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure","volume":"46","author":"Shah","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2008.06.012_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cardfail.2003.10.012","article-title":"How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?","volume":"10","author":"Svensson","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.contraception.2008.06.012_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin\u2013angiotensin\u2013aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMp048144","article-title":"Treatment of heart failure with spironolactone \u2014 trial and tribulations","volume":"351","author":"McMurray","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.06.012_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2165\/00002018-200427130-00003","article-title":"Safety of a new oral contraceptive containing drospirenone","volume":"27","author":"Heinemann","year":"2004","journal-title":"Drug Safety"},{"issue":"4","key":"10.1016\/j.contraception.2008.06.012_bib22","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Farquhar","year":"2003","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408003429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408003429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T13:28:23Z","timestamp":1545830903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408003429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0010782408003429"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.06.012","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}